Committee on Public Health - November 14, 2019

11/14/2019

Attendance Alan Ashare, MD  Julia A. Benedetti, MD Libby Bradshaw, DO James Broadhurst, MD, Chair David M. Crandell, MD Louis Fazen, III, MD, MPH Nancy Hurley, MD Janet Jankowiak, MD Michael Lew, MD Lisa Matthews, MD Barbara Moore, MD David P. Norton MD   Sally Reyering, MD Rebekah Rollston, MD Beri Song

/Templates/Article.aspx?id=4294985079

Reference Committee C Report

11/13/2019

not find a link between length of time to complete requirements and competency. The report also feels … Findings – consent calendar listen to discussion. This resolution reviews problems with communications …

/Governance-and-Leadership/MA-Delegation-to-the-AMA/Reference-Committee-C-Report/

Committee on Preparedness - November 5, 2019

11/5/2019

Attendees Ritu Sarin, MD, Chair Kevin Ryan, MD, Vice-Chair Alfred DeMaria, MD (Advisor) Christopher Barsotti, MD Catherine Brown, DVM, MSc, MPH (Advisor) Michael DeLuca, MD, MS Henry Dorkin, MD (Advisor) Scott Goldberg, MD, MPH Christina Hernon, MD Kenneth Knowles, MD Stacey Kokaram, MPH Michael McHugh, MD  Ira

/Templates/Article.aspx?id=4294985082

Committee on Mental Health and Substance Use - November 4, 2019

11/4/2019

/Templates/Article.aspx?id=4294985571

Activity Planning Document (pdf)

10/30/2019

□ Hospital/clinic QA data and/or analyses□ Research findings □ Guidelines Sources: 1. 2 …

/Continuing-Education-and-Events/Joint-Providership/Activity-Planning-Document-(pdf)-42949670017/

Special Committees Report IM 2019

10/29/2019

Markers of Equivalency and agreed with the MMS compliance findings. 37 38 To meet the other Markers … of the 2019 annual 41 fees, submission of accreditation findings and/progress report decisions, and 42 … that save money, and how some physicians find activism on 35 climate change helpful in countering …

/specialcomm/

Keynote - MMS Public Health Leadership Forum Oct 2019

10/24/2019

Opioid Death Rate by Race/Ethnicity 53% 8.4% 79.5% 51% 10% 96% 4% • Key Finding …

/PHLF19-Keynote/

Question 1

10/16/2019

Ms. Smith is a 32 yo woman with a past medical history significant for opioid use disorder and hepatitis C who presents for evaluation. She has had prior episodes of recovery and feels she has benefited from use of naltrexone IM injections. She has, however, relapsed many times and after her most recent relapse she

/Templates/Article.aspx?id=4294991902

Testimony in Support of An Act Relative to Preventing Overdose Deaths and Increasing Access to Treatment 2019

10/1/2019

in the Commonwealth. Among other important findings, the Commission recommended that, to continue fighting the opioid …, and tended to inject in public spaces. These findings suggest that SIFs are used by the most vulnerable … individual human dignity and rights. The MMS Task Force’s findings are consistent with those …

/Templates/Article.aspx?id=4294983901

Proceedings 2016

9/27/2019

/Governance-and-Leadership/House-of-Delegates/Annual-Meeting/Proceedings-2016/